Pharnext Company

Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.

Headquarters: Issy-les-moulineaux, Ile-de-France, France
Industry: Neurodegenerative disease diagnosis and treatment
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Investors Number: 4.0
Funding Status: IPO
Technology: Biopharma, Biotechnology, Medical, Neuroscience, Pharmaceutical
Last Funding Type: Post-IPO Equity
Founded Date: 2007-04-01
Total Funding: 157576441.0
Last Funding Date: 2021-06-07